Targeting human dendritic cell subsets for improved vaccines

Hideki Ueno, Eynav Klechevsky, Nathalie Schmitt, Ling Ni, Anne Laure Flamar, Sandra Zurawski, Gerard Zurawski, Karolina Palucka, Jacques Banchereau, Sang Kon Oh

Research output: Contribution to journalReview articlepeer-review

66 Scopus citations


Dendritic cells (DCs) were discovered in 1973 by Ralph Steinman as a previously undefined cell type in the mouse spleen and are now recognized as a group of related cell populations that induce and regulate adaptive immune responses. Studies of the past decade show that, both in mice and humans, DCs are composed of subsets that differ in their localization, phenotype, and functions. These progresses in our understanding of DC biology provide a new framework for improving human health. In this review, we discuss human DC subsets in the context of their medical applications, with a particular focus on DC targeting.

Original languageEnglish
Pages (from-to)21-27
Number of pages7
JournalSeminars in Immunology
Issue number1
StatePublished - Feb 2011
Externally publishedYes


  • Antibody responses
  • Cytotoxic T lymphocyte responses
  • DC targeting
  • Dendritic cell subsets
  • Human
  • Vaccines


Dive into the research topics of 'Targeting human dendritic cell subsets for improved vaccines'. Together they form a unique fingerprint.

Cite this